Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erpenbeck

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
Nature Communications|September 16, 2018
Chromatin swelling drives neutrophil extracellular trap releaseElsa Neubert, Daniel Meyer, Francesco Rocca, et al.
Nanoscale|April 15, 2020
Transport and programmed release of nanoscale cargo from cells by using NETosisDaniel Meyer, Saba Telele, Anna Zelená, et al.
Biology Open|May 13, 2025
Primary human neutrophils and monocytes migrate along endothelial cell boundaries to optimize search efficiency under static in vitro conditionsNele Honig, Christina Teubert, Lucas Lamparter, et al.
Plos One|May 5, 2012
Global diversity of sponges (Porifera)Rob W M Van Soest, Nicole Boury-Esnault, Jean Vacelet, et al.
The Journal of Allergy and Clinical Immunology|March 3, 2019
Fevipiprant, a selective prostaglandin D<sub>2</sub> receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and functionClare Hardman, Wentao Chen, Jian Luo, et al.
Respiratory Research|March 1, 2006
Lung fibroblasts from patients with emphysema show markers of senescence in vitroK-C Müller, L Welker, K Paasch, et al.
Theranostics|April 25, 2017
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skinMartin Metz, Petra Staubach, Andrea Bauer, et al.
International Archives of Allergy and Immunology|September 6, 2012
Omalizumab protects against allergen- induced bronchoconstriction in allergic (immunoglobulin E-mediated) asthmaStefan Zielen, Adrian Lieb, Stephan De La Motte, et al.
Plos One|November 14, 2019
Correction: KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web ServicesJulian Gruendner, Thorsten Schwachhofer, Phillip Sippl, et al.
Plos One|October 4, 2019
KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web ServicesJulian Gruendner, Thorsten Schwachhofer, Phillip Sippl, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
Nature Communications|September 16, 2018
Chromatin swelling drives neutrophil extracellular trap releaseElsa Neubert, Daniel Meyer, Francesco Rocca, et al.
Nanoscale|April 15, 2020
Transport and programmed release of nanoscale cargo from cells by using NETosisDaniel Meyer, Saba Telele, Anna Zelená, et al.
Biology Open|May 13, 2025
Primary human neutrophils and monocytes migrate along endothelial cell boundaries to optimize search efficiency under static in vitro conditionsNele Honig, Christina Teubert, Lucas Lamparter, et al.
Plos One|May 5, 2012
Global diversity of sponges (Porifera)Rob W M Van Soest, Nicole Boury-Esnault, Jean Vacelet, et al.
The Journal of Allergy and Clinical Immunology|March 3, 2019
Fevipiprant, a selective prostaglandin D<sub>2</sub> receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and functionClare Hardman, Wentao Chen, Jian Luo, et al.
Respiratory Research|March 1, 2006
Lung fibroblasts from patients with emphysema show markers of senescence in vitroK-C Müller, L Welker, K Paasch, et al.
Theranostics|April 25, 2017
Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skinMartin Metz, Petra Staubach, Andrea Bauer, et al.
International Archives of Allergy and Immunology|September 6, 2012
Omalizumab protects against allergen- induced bronchoconstriction in allergic (immunoglobulin E-mediated) asthmaStefan Zielen, Adrian Lieb, Stephan De La Motte, et al.
Plos One|November 14, 2019
Correction: KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web ServicesJulian Gruendner, Thorsten Schwachhofer, Phillip Sippl, et al.
Plos One|October 4, 2019
KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web ServicesJulian Gruendner, Thorsten Schwachhofer, Phillip Sippl, et al.
Pageof 29